Proprio vs Idexx Laboratories
Side-by-side comparison of AI visibility scores, market position, and capabilities
Proprio builds the Paradigm AI surgical guidance platform, providing radiation-free 3D real-time anatomy visualization and intraoperative spinal alignment measurements for spine surgeons.
About
Proprio is a Seattle-based surgical technology company founded in 2016 by CEO Gabriel Jones alongside neurosurgeon Dr. Samuel Browd, University of Washington Professor Joshua Smith, and computer vision specialist James Youngquist. The company develops Paradigm, an FDA-cleared AI surgical guidance platform that uses light-field imaging, optical tracking, depth sensors, and infrared cameras to build a real-time 3D model of the surgical field without ionizing radiation.
Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.
About
IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.